Summit Therapeutics携手Lunit达成协议,将AI驱动的Scope IO平台应用于免疫肿瘤学开发中的肿瘤微环境分析

美股速递
8 hours ago

Summit Therapeutics与Lunit宣布达成一项合作协议,双方将把人工智能驱动的Scope IO平台引入免疫肿瘤学开发领域,用于肿瘤微环境的深入分析。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10